Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus

Neuropathology and Applied Neurobiology

Volumn 25, Issue 1, 1999, Pages 10-18

  Montgomery, M M ^a   Dean, A F ^b   Taffs, F ^c   Stott, E J ^c   Lantos, P L ^b   Luthert, P J ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

AIDS; Central nervous system; Cynomolgus macaque; Dendrite; Microtubule associated protein 2; Neuronal pathology; Simian immunodeficiency

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; ENCEPHALITIS; FEMALE; FRONTAL CORTEX; GIANT CELL; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACACA; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SIMIAN IMMUNODEFICIENCY VIRUS; SPINE; VIRUS LOAD;

EID: 0033023490     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1999.00163.x     Document Type: Article

References (53)

1. 1 Bagetta G, Corasaniti MT, Berliocchi L, Navarra M, Finazzi Agro A, Nistico G. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem Biophys Res Commun 1995; 211: 130-6
2. 2 Baskerville A, Ramsay AD, Addis BJ et al. Interstitial pneumonia in simian immunodeficiency virus infection. J Pathol 1992; 167: 241-7
3. 3 Brenneman DE, McCune SK, Mervis RF, Hill JM. gp120 as an etiologic agent for NeuroAIDS. neurotoxicity and model systems. Adv Neuroimmunol 1994; 4: 157-65
4. 4 Brenneman DE, Westbrook GL, Fitzgerald SP et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988; 335: 639-42
5. 5 Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J Neurol Neurosurg Psychiatry 1994; 57: 784-9
6. 6 Bukrinsky MI, Nottet HS, Schmidtmayerova H et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735-45
7. 7 Dean AF, Montgomery M, Baskerville A et al. Different patterns of neuropathological disease in rhesus monkeys infected by simian immunodeficiency virus, and their relation to the humoral immune response. Neuropathol Appl Neurobiol 1993; 19: 336-45
8. 8 Dwyer DE, Matheron S, Bakchine S, Bechet JM, Montagnier L, Vazeux R. Detection of human immunodeficiency virus type 2 in brain tissue. J Infect Dis 1992; 166: 888-91
9. 9 Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 1993; 33: 429-36
10. 10 Everall I, Luthert P, Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993; 52: 561-6
11. 11 Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991: 337: 1119-2
12. 12 Everall IP, Luthert PJ, Lantos PL. Neuronal number and, Vol. alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 1993; 56: 481-6
13. 13 Felipo V, Grau E, Minana MD, Grisolia S. Activation of NMDA receptor mediates the toxicity of ammonia and the effects of ammonia on the microtubule-associated protein MAP-2. Adv Exp Med Biol 1993; 341: 83-93
14. 14 Ferrer I, Gullotta F. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol Berl 1990; 79: 680-5
15. 15 Gelbard HA, Nottet HS, Swindells S et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994; 68: 4628-35
16. 16 Giangaspero F, Scanabissi E, Baldacci MC, Betts CM. Massive neuronal destruction in human immunodeficiency virus (HIV) encephalitis. A clinico-pathological study of a pediatric case. Acta Neuropathol Berl 1989; 78: 662-5
17. 17 Giulian D, Wendt E, Vaca K, Noonan CA. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993; 90: 2769-73
18. 18 Giulian D, Yu J, Li X et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 1996; 16: 3139-53
19. 19 Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996; 274: 1383-5
20. 20 Hayami M, Ido E, Miura T. Survey of simian immunodeficiency virus among nonhuman primate populations. In: Simian Immunodeficiency Viru., Eds. NL Letvin, RC Desrosiers. Berlin: Springer-Verlag, 1994: 1-20
21. 21 Heyes MP, Saito K, Crowley JS et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain; 1992: 115: 1249-73
22. 22 Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 1993; 603: 222-33
23. 23 Hirsch VM, Dapolito G, Goeken R, Campbell BJ. Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr Opin Genet Dev 1995; 5: 798-806
24. 24 Hogan RN, Baringer JR, Prusiner SB. Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: a quantitative Golgi analysis. J Neuropathol Exp Neurol 1987; 46: 461-73
25. 25 Huttenlocher PR. Dendritic and synaptic pathology in mental retardation. Pediatr Neurol 1991; 7: 79-85
26. 26 Jagadha V, Becker LE. Dendritic pathology: an overview of Golgi studies in man. Can J Neurol Sci 1989; 16: 41-50
27. 27 Kaufmann WE, Naidu S, Budden S. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 1995; 26: 109-13
28. 28 Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol Berl 1990; 80: 92-4
29. 29 Koczyk D. Differential response of microtubule-associated protein 2 (MAP-2) in rat hippocampus after exposure to trimethyltin (TMT): an immunocytochemical study. Acta Neurobiol Exp Warsz 1994; 54: 55-8
30. 30 Kremer HP, Roos RA, Dingjan G, Marani E, Bots GT. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J Neuropathol Exp Neurol 1990; 49: 371-82
31. 31 Lackner AA, Smith MO, Munn RJ et al. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 1991; 139: 609-21
32. 32 Lescaudron L, Jaffard R, Verna A. Modifications in number and morphology of dendritic spines resulting from chronic ethanol consumption and withdrawal: a Golgi study in the mouse anterior and posterior hippocampus. Exp Neurol 1989; 106: 156-63
33. 33 Lipton SA. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci 1994; 16: 145-51
34. 34 Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991; 7: 111-8
35. 35 Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992; 32: 321-9
36. 36 Masliah E, Ge N, Achim CL, Wiley CA. Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 1995; 54: 350-7
37. 37 Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992; 66: 285-91
38. 38 Matesic DF, Lin RC. Microtubule-associated. J Neurochem 1994; 63: 1012-20
39. 39 McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47: 425-32
40. 40 Multani P, Myers RH, Blume HW, Schomer DL, Sotrel A. Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study. Epilepsia 1994; 35: 728-36
41. 41 Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992; 255: 1246-9
42. 42 Murray M, Wang SD, Goldberger ME, Levitt P. Modification of astrocytes in the spinal cord following dorsal root or peripheral nerve lesions. Exp Neurol 1990; 110: 248-57
43. 43 Nagra RM, Masliah E, Burrola PG, Wiley CA. Neocortical pathology in chronic murine retroviral encephalitis. J Neuropathol Exp Neurol 1994; 53: 572-81
44. 44 Olah Z, Lehel C, Anderson WB, Brenneman DE, van Agoston D. Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J Neurosci Res 1994; 39: 355-63
45. 45 Park JS, Bateman MC, Goldberg MP. Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation. Neurobiol Dis 1996; 3: 215-27
46. 46 Rausch DM, Heyes MP, Murray EA et al. Cytopathologic and neurochemical correlates of progression to motor/ cognitive impairment in SIV-infected rhesus monkeys. J Neuropathol Exp Neurol 1994; 53: 165-75
47. 47 Ringler DJ, Hunt RD, Desrosiers RC, Daniel MD, Chalifoux LV, King NW. Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann Neurol 1988; 23 (Suppl.): S101-7
48. 48 Rose J, Silvera P, Flanagan B, Kitchin P, Almond N. The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J Virol Methods 1995; 51: 229-39
49. 49 Royal W, Selnes OA, Concha M, Nance Sproson TE, McArthur JC. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann Neurol 1994; 36: 32-9
50. 50 Singer EJ, Syndulko K, Fahy Chandon BN et al. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 1994; 8: 197-204
51. 51 Weihe E, Nohr D, Sharer L, Murray E, Rausch D, Eiden L. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus. Neuroreport 1993; 4: 263-6
52. 52 Whitaker Azmitia PM, Borella A, Raio N. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia? Neuropsychopharmacology 1995; 12: 269-72
53. 53 Wiley CA, Masliah E, Morey M et al. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651-7